BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News

Alzheimer's Disease News Articles

Get Our Industry eNewsletter FREE email:    
 Top Breaking News
PRANA Biotechnology Tanks As Lead Drug Fails Alzheimer's Study     4/1/2014   More...
Anavex Life Sciences Corp. Successfully Closes $10 Million Financing To Initiate Phase 1b/2a Alzheimer's Clinical Trial     3/19/2014   More...
Biogen Idec, Inc. (Massachusetts) Buys Rights To Eisai Company, Ltd. Alzheimer's Drugs, Amount Undisclosed     3/5/2014   More...
Forest Laboratories, Inc. To Discontinue NAMENDA® Tablets, Focus On Once-Daily NAMENDA XR®     2/17/2014   More...
AstraZeneca PLC Takes On Merck & Co., Inc. In Alzheimer's Drug Race     2/7/2014   More...
Doc Admits He Leaked Secret ALZ's Trial Information To "Friend" At SAC     1/21/2014   More...
Investors Bet $22 Million On AC Immune SA, Will Start World's First Anti-Ptau Vaccine Trial For Alzheimer's Disease     1/10/2014   More...
Johnson & Johnson, Orion Corporation, Ink $31 Million+ Alzheimer's Pact     12/20/2013   More...
Merck & Co., Inc. Moves Alzheimer's Drug Into Big Trials After Safety Review     12/10/2013   More...
Biogen Idec, Inc. (Massachusetts), Proteostasis Therapeutics, Inc. Hammer Out $200 Million+ Pre-Clinical Alzheimer's Pact     12/9/2013   More...
Aphios Spins Off Amylon LLC To Develop Novel Alzheimer’s Disease Drug     11/20/2013   More...
New Massachusetts-Based Startup Alzheon Launches With Veteran Team, Funding and Hunts for Alzheimer's Castoffs     10/23/2013   More...
Eli Lilly and Company Disappointed in Medicare Decision on Amyvid™     9/30/2013   More...
Early Successful Results for Merck & Co., Inc.'s Alzheimers Drug     7/18/2013   More...
Lundbeck Inc. and Otsuka Pharmaceutical Co., Ltd. Release: Phase II Clinical Data Show Statistically Sgnificant Improvement for Lu AE58054 as Addon to Donepezil, Versus donepezil Alone, on Cognitive Symptoms of Alzheimer's Disease     7/17/2013   More...
 Featured Stories
Women Are More Vulnerable To Alzheimer's Gene, Stanford University School of Medicine Study     4/15/2014   More...
Cognitive Decline May Decrease Risk Of Cancer Mortality, University Hospital In Madrid Study     4/11/2014   More...
Drink Coffee To Ward Off Alzheimer’s, University of Bonn Study     4/9/2014   More...
More Research Links Poor Heart Health With Alzheimer's Risk, Wake Forest University Study     4/2/2014   More...
New Therapeutic Target Discovered For Alzheimer's Disease, University of California, San Diego (UCSD) Study     3/18/2014   More...
Blood Test Predicts Alzheimer's Disease, Georgetown University Medical Center Study     3/11/2014   More...
Inherited Alzheimer's Damage Is Done Before Symptoms Appear, University of Melbourne Study     3/11/2014   More...
Alzheimer’s In A Dish, Harvard University Study     3/6/2014   More...
Alzheimer’s Estimated To Be No. 3 Killer Disease In U.S., Rush University Medical Center Study     3/6/2014   More...
Alzheimer's Disease Risk Higher In People When Both Parents Have AD, New York University School of Medicine Study     2/13/2014   More...
Banned Pesticide Linked To Alzheimer's Disease, Rutgers University Study     1/29/2014   More...
Alzheimer's Risk Gene May Begin To Affect Brains In Childhood, Centre For Addiction And Mental Health Study     12/4/2013   More...
Can The Eyes Help Diagnose Alzheimer's Disease? Georgetown University Medical Center Study     11/15/2013   More...
Major Alzheimer's Risk Factor Linked to Red Wine Target, Buck Institute for Age Research Study     10/23/2013   More...
Common Blood Pressure Drugs Decrease Risk of Alzheimer's Disease, Johns Hopkins University Study     10/18/2013   More...
 More News
New Company Pharmasum Therapeutics Aims To Fast Track Development Novel Protein Kinease Inhibitors For Alzheimer's And Dementia     4/15/2014   More...
CogState Ltd (CGS.AX) Release: Early Detection Of Alzheimer's Disease Enables Caregivers To Significantly Delay Admission Of Their Loved Ones To Nursing Homes     4/9/2014   More...
Anavex Life Sciences Corp. (AVXL.OB) Strengthens Alzheimer's Pipeline, Obtains Exclusive Worldwide Rights To Intellectual Property     3/31/2014   More...
Anavex Life Sciences Corp. (AVXL.OB) Reports Predicted Clinical Effect Of Both ANAVEX 2-73 And ANAVEX PLUS In A Humanized Cortical Cognitive Model For Alzheimer's Disease     3/28/2014   More...
CogState Ltd (CGS.AX)'s Technology Chosen For Major Phase 3 Trial Of Alzheimer's Disease Drug     3/25/2014   More...
Forest Laboratories, Inc. (FRX) And Adamas Pharmaceuticals Announce Forest’s Submission Of New Drug Application For Memantine Extended Release And Donepezil Fixed-Dose Combination For Alzheimer’s Disease     3/4/2014   More...
Vitae Pharmaceuticals, Inc. Earns $14 Million Milestone Payment From Boehringer Ingelheim Corporation In Alzheimer's Collaboration     2/20/2014   More...
Takeda Pharmaceutical Co. Ltd. (TKPYY) Joins The Global CEO Initiative On Alzheimer's Disease     2/20/2014   More...
Neuronetrix, Inc. Completes Significant Clinical Study Milestone Using The COGNISION™ System For Early Diagnosis Of Alzheimer's Disease     2/12/2014   More...
The Michael J. Fox Foundation: Crossing The Lines Between Parkinson's And Alzheimer's     2/5/2014   More...
Anavex Life Sciences Corp. (AVXL.OB) Release: Sigma-1 Receptor Implicated In Cell Survival Of Rare Neurodegenerative Diseases - Expanding The Opportunity For Application Of ANAVEX PLUS In Rare Diseases     1/23/2014   More...
Cortice Biosciences Announces Enrollment Of A Clinical Trial Targeting Tau Dysfunction In Mild-To-Moderate Alzheimer's Disease     1/22/2014   More...
Cortice Biosciences Announces Enrollment Of A Clinical Trial Targeting Tau Dysfunction In Mild-To-Moderate Alzheimer's Disease     1/21/2014   More...
Anavex Life Sciences Corp. (AVXL.OB) Agreement With The Roskamp Institute To Advance The Clinical Development Of ANAVEX PLUS     1/13/2014   More...
Akili Interactive Labs Announces Partnership With Pfizer Inc. (PFE) To Test Video Game In People At Risk Of Alzheimer's Disease     1/9/2014   More...

 

 

//-->